Recovery from hypogonadism in men with prolactinoma treated with dopamine agonists

A Comparison of Cabergoline and Bromocriptine in the Treatment of Hyperprolactinemic Amenorrhea

Jonathan Webster, G. Piscitelli, Anna Polli et al. · New England Journal of Medicine · 1994 · 700 citations · Full text

Medicine, Endocrinology, Pharmacology +7

Primary Medical Therapy of Micro- and Macroprolactinomas in Men*

Joseph J. Pinzone, Laurence Katznelson, Daniel C. Danila et al. · The Journal of Clinical Endocrinology & Metabolism · 2000 · 138 citations

Medicine, Endocrinology, Oncology +11

The association of obesity with sex hormone‐binding globulin is stronger than the association with ageing – implications for the interpretation of total testosterone measurements

Lori A. Cooper, Stephanie T. Page, John K. Amory et al. · Clinical Endocrinology · 2015 · 113 citations · Full text

Medicine, Endocrinology, Andrology +16

The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas

Antonella Di Sarno, Maria Luisa Landi, Paolo Marzullo et al. · Clinical Endocrinology · 2000 · 98 citations

Medicine, Endocrinology, Pharmacology +14

The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males

Michele De Rosa, Antonio Ciccarelli, Stefano Zarrilli et al. · Clinical Endocrinology · 2006 · 76 citations

Veterinary Medicine, Endocrinology, Urology +17